85 results
Page 2 of 5
SC TO-T
EX-99
5ly3zr8csbb9v2pcc
1 Dec 22
Third party tender offer statement
6:06am
8-K
EX-99.1
dlihr4v94x7ecwjly bp
29 Nov 22
Viatris Completes Biosimilars Transaction with Biocon Biologics
8:29am
SC TO-C
EX-99.2
ujdlhy3l
7 Nov 22
Information about tender offer
5:26pm
SC TO-C
EX-99.1
8yisrulxwu 433
7 Nov 22
Information about tender offer
5:26pm
8-K
EX-99.1
s9lax
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.2
92xdi 5a9eoj6
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.1
vw5arn
7 Nov 22
Viatris Reports Strong Third Quarter 2022 Results
7:41am
8-K
EX-99.1
iv5nbhh
8 Aug 22
Viatris Reports Strong Second Quarter 2022 Results
8:02am
8-K
EX-99.1
rl3zgbcbxdimgulwy71
9 May 22
Viatris Reports Strong First-Quarter 2022 Results
8:15am
8-K
EX-2.1
w9v8tp2c 7hp
28 Feb 22
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-99.1
3x89 9zg2
28 Feb 22
Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results and Issues 2022 Financial Guidance
8:24am
8-K
EX-99.1
o2f9391g0
8 Nov 21
Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Board of Directors Declares Quarterly Dividend of Eleven Cents ($0.11) per Share
8:27am
DEF 14A
lpgmwlibxi
29 Oct 21
Definitive proxy
4:35pm